Business Description
NeuroSense Therapeutics is an Israeli medical company working to develop new medicines for people living with serious brain-related illnesses such as ALS, Alzheimer's, and Parkinson's disease. Its most advanced drug candidate, PrimeC, combines two existing medications into a single oral pill and is currently being tested in late-stage clinical trials for ALS, with earlier trials completed for Alzheimer's. The company also has additional drug candidates in earlier stages of research targeting both Parkinson's and Alzheimer's diseases.
